ADAPTIMMUNE THERAPEUTICS PLC
NASDAQ: ADAP (Adaptimmune Therapeutics plc)
Last update: 8 hours ago0.136
-0.01 (-9.67%)
| Previous Close | 0.150 |
| Open | 0.142 |
| Volume | 56,824,261 |
| Avg. Volume (3M) | 73,990,428 |
| Market Cap | 35,914,492 |
| Price / Sales | 0.510 |
| Price / Book | 2.68 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2025 |
| Profit Margin | -38.91% |
| Operating Margin (TTM) | -604.96% |
| Diluted EPS (TTM) | -0.300 |
| Quarterly Revenue Growth (YOY) | 28.30% |
| Total Debt/Equity (MRQ) | 626.29% |
| Current Ratio (MRQ) | 2.02 |
| Operating Cash Flow (TTM) | -107.85 M |
| Levered Free Cash Flow (TTM) | -30.50 M |
| Return on Assets (TTM) | -14.19% |
| Return on Equity (TTM) | -275.74% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Adaptimmune Therapeutics plc | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -1.50 |
|
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 0.63% |
| % Held by Institutions | 44.16% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |